Abstract
Introduction: Patients undergoing cardiac bridge to transplantation (BTT) with HeartMate II (HMII) implantation can be stratified according to INTERMACS score, Right Ventricular Failure Risk Score (RVFRS), and composite pre-operative mortality risk scores, which allow improved patient selection for Left Ventricular Assist Device (LVAD) implantation and possible prediction of patient survival postoperatively. Hypothesis: High risk INTERMACS scores, RVFRS, and composite preoperative mortality risk scores may confer lower survival in our patient population implanted with HM II LVAD as BTT.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
